Tetrac

Overview

Tetrac (Tetraiodothyroacetic acid), a derivative of L-thyroxine (T4), is a thyrointegrin receptor antagonist. Tetrac blocks the actions of T4 and 3,5,3'-triiodo-L-thyronine (T3) at the cell surface receptor for thyroid hormone on integrin αvβ3 . Tetra has anti-angiogenic and anti-tumor activities.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Integrin | Products > Signaling Pathways > Endogenous Metabolite

Product Information

• Catalog No.: HY-W008859
• CAS No.: 67-30-1
• Molecular Formula: C14H8I4O4
• Molecular Weight: 747.83
• Purity: 99.21%
• Storage: -20°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: 2.5 mg/mL (3.34 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source